Valuation: Coral Laboratories Limited

Market Cap 185.78Cr 1.95Cr 1.75Cr 1.61Cr 1.46Cr 2.73Cr 2.77Cr 19Cr 7.67Cr 97Cr 7.32Cr 7.17Cr 307.94Cr P/E 2025
10.4x
P/E 2026 8.08x
Enterprise Value 159.4Cr 1.67Cr 1.5Cr 1.38Cr 1.25Cr 2.34Cr 2.38Cr 17Cr 6.58Cr 83Cr 6.28Cr 6.15Cr 264.22Cr EV / Sales 2025
1.94x
EV / Sales 2026 1.23x
Free-Float
19.97%
Yield 2025
0.21%
Yield 2026 0.54%
1 day+3.71%
1 week+1.12%
Current month-8.46%
1 month-4.81%
3 months-9.84%
6 months+23.74%
Current year+18.59%
1 week 475.7
Extreme 475.7
536
1 month 475.7
Extreme 475.7
638.7
Current year 360
Extreme 360
679
1 year 360
Extreme 360
679
3 years 275.1
Extreme 275.1
999
5 years 217
Extreme 217
999
10 years 81.2
Extreme 81.2
1,190
Manager TitleAgeSince
Director of Finance/CFO 49 26/05/2017
Director TitleAgeSince
Director/Board Member 45 26/05/2017
Director/Board Member 49 26/05/2017
Director/Board Member 40 28/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
+3.71%+1.12%+7.06%+80.18% 1.88Cr
+6.63%+8.10%+67.50%+145.20% 1,14800Cr
+1.53%+6.76%+47.22%+89.01% 65TCr
+1.68%+2.10%+27.80%+109.31% 51TCr
+0.73%+2.47%+53.85%+68.96% 38TCr
+3.83%-2.37%+68.14%+42.32% 35TCr
+2.38%+4.27%+33.81%+57.95% 29TCr
+2.26%+3.47%+5.21%+28.92% 26TCr
+1.97%+5.11%+57.74%+76.14% 24TCr
+4.03%+7.84%+40.49%+116.14% 20TCr
Average +3.57%+1.00%+40.88%+81.41% 40.37TCr
Weighted average by Cap. +3.91%+1.50%+49.58%+95.97%

Financials

2025 2026
Net sales 115.01Cr 1.21Cr 1.08Cr 99.8L 90.31L 1.69Cr 1.72Cr 12Cr 4.75Cr 60Cr 4.53Cr 4.44Cr 190.63Cr 86Cr 90.2L 80.8L 74.54L 67.45L 1.26Cr 1.28Cr 8.89Cr 3.55Cr 45Cr 3.39Cr 3.31Cr 142.39Cr
Net income 24Cr 25.37L 22.72L 20.96L 18.97L 35.47L 36.04L 2.5Cr 99.77L 13Cr 95.2L 93.17L 40Cr 16Cr 17.2L 15.41L 14.21L 12.86L 24.05L 24.44L 1.7Cr 67.66L 8.57Cr 64.56L 63.18L 27Cr
Net Debt -27Cr -28.76L -25.76L -23.77L -21.51L -40.22L -40.87L -2.84Cr -1.13Cr -14Cr -1.08Cr -1.06Cr -45Cr -26Cr -27.69L -24.81L -22.88L -20.71L -38.72L -39.35L -2.73Cr -1.09Cr -14Cr -1.04Cr -1.02Cr -44Cr
Projected Income Statement - Annual - Coral Laboratories Limited
Logo Coral Laboratories Limited
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
Employees
149
Date Price Change Volume
29/26/29 ₹520.00 +3.71% 743
28/26/28 ₹501.40 +2.09% 112
27/26/27 ₹491.15 -1.75% 406
26/26/26 ₹499.90 +1.17% 522
23/26/23 ₹494.10 -2.53% 2,855
  1. Stock Market
  2. Stocks
  3. CORALAB6 Stock